相关实验视频

Updated: May 23, 2025

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

鉴定与端粒相关的基因亚型和骨髓瘤的预后特征

Zhaoguang Song¹, Wenyan Yu², Xuqing Yin³

¹Department of West Hospital Orthopaedic Trauma, Zibo Central Hospital, Zibo, China.

Frontiers in pharmacology

|March 12, 2025

概括

这项研究根据与端粒相关的基因 (TRG) 确定了两种骨髓瘤 (OS) 亚型,揭示了不同的免疫特征和生存结果. 一个新的TRG签名有助于预测OS预后和潜在的治疗策略.

科学领域:

在瘤学瘤学.
遗传学是一个遗传学.
免疫学免疫学免疫学

背景情况:

骨髓瘤 (OS) 是一种具有高转移潜力的原发性骨癌.
在OS中,与端粒相关基因 (TRGs) 的预后意义尚不清楚.
识别基于TRG的亚型可以阐明OS异质性.

研究的目的:

在骨髓瘤 (OS) 中识别与端粒相关的亚型.
分析这些亚型的免疫特征.
为OS开发基于TRG的预后签名.

主要方法:

从 TARGET 和 Gene Expression Omnibus 数据库中收集的操作系统数据.
确定了TRG介导的亚型,并分析了它们的免疫特征.
开发了一个使用单变量和LASSO Cox回归的预后签名,评估其与瘤微环境 (TME) 的相关性.

主要成果:

发现了两种TRG定义的OS亚型 (C1和C2),生存率不同 (C2低于C1).
亚型C1表现出增加的 stromal,免疫和ESTIMATE得分,与C2.2相比,瘤纯度降低.
建立了一个六基因预后模型 (PDK2,PPARG,MORC4,SP110,TERT,MAP3K5),与OS预后和TME相关,OS细胞表达减少.

结论:

与端粒相关的基因定义了不同的OS亚型,具有不同的生存和免疫特征.
开发的TRG签名是OS预后和指导TME向治疗的潜在工具.

关键词:

分子亚型分子亚型骨质肉瘤是骨质肉瘤的一种疾病.预测模型的预测模型.与端粒相关的基因瘤微环境是一个微环境.

更多相关视频

Author Spotlight: RNA FISH for Locating lncRNA-SNHG6 in Osteosarcoma Cells

Author Spotlight: RNA FISH for Locating lncRNA-SNHG6 in Osteosarcoma Cells

Published on: June 16, 2023

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Published on: June 13, 2018

相关概念视频

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Replicative Cell Senescence

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...